反応 #1833219
ord-57d540e011964362ae5e4b8522152bf3
反応方程式
反応物
試薬
反応条件
後処理
- 1workup.STIRRINGthe mixture was stirred for 2 h at −75° C
- 2workup.STIRRINGstirring
- 3workup.WAITwas continued for 1.5 h
- 4洗浄The ether phase was washed with saturated NaCl (10 mL)
- 5乾燥dried (Na2SO4)
- 6その他evaporated under vacuum
- 7その他The residue was purified by chromatography on silica with hexane
- 8その他repurified by reverse-phase
実験手順
2,2,6,6-Tetramethylpiperidine (2.1 mL, 1.8 g, 12 mmol) was dissolved in dry tetrahydrofuran (15 mL), cooled to −75° C. and treated with n-butyllithium (n-BuLi, 2.5 M; 4.8 mL, 12 mmol), and the mixture was stirred for 30 min at −75° C. 5-Bromo-2,2-difluorobenzo[d][1,3]dioxole (2.0 g, 8.4 mmol) was added, and the mixture was stirred for 2 h at −75° C. 1,1,2-Trichloro-1,2,2-trifluoroethane (2.4 mL, 3.8 g, 20 mmol) was added and stirring was continued for 1.5 h. Saturated NH4Cl (10 mL) was added, and the mixture was shaken with diethyl ether (30 mL) and water (20 mL). The ether phase was washed with saturated NaCl (10 mL), dried (Na2SO4) and evaporated under vacuum. The residue was purified by chromatography on silica with hexane and then repurified by reverse-phase HPLC using 75% acetonitrile to give the title compound as a clear liquid (640 mg, 28%): 1H NMR (400 MHz, CDCl3) δ 7.38 (dd, J=8.5, 5.1 Hz, 1H), 6.90 (dd, J=9.0, 4.7 Hz, 1H); EIMS m/z 332.